Cargando…
JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms
The JAK2V617F variant constitutes a genetic alteration of higher frequency in BCR/ABL1 negative chronic myeloproliferative neoplasms, which is caused by a substitution of a G ˃ T at position 1849 and results in the substitution of valine with phenylalanine at codon 617 of the polypeptide chain. Clin...
Autores principales: | Torres, Dania G., Paes, Jhemerson, da Costa, Allyson G., Malheiro, Adriana, Silva, George V., Mourão, Lucivana P. de Souza, Tarragô, Andréa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961666/ https://www.ncbi.nlm.nih.gov/pubmed/35204792 http://dx.doi.org/10.3390/biom12020291 |
Ejemplares similares
-
The Contribution of JAK2 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms
por: Paes, Jhemerson, et al.
Publicado: (2022) -
Molecular landscape of the JAK2 gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil
por: Torres, Dania G., et al.
Publicado: (2023) -
Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview
por: de Freitas, Renata Mendes, et al.
Publicado: (2015) -
Mouse models of myeloproliferative neoplasms: JAK of all grades
por: Li, Juan, et al.
Publicado: (2011) -
The JAK2 gene as a protagonist in chronic
myeloproliferative neoplasms
por: de Freitas, Renata Mendes, et al.
Publicado: (2013)